February 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Commvault Systems, Inc. (“Commvault” or “the Company”) (NASDAQ: CVLT). Investors who purchased Commvault securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Commvault has violated… read more
February 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ralliant Corporation (“Ralliant” or “the Company”) (NYSE: RAL). Investors who purchased Ralliant securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ralliant has violated federal… read more
February 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the take-private agreement between European Wax Center, Inc. (“European Wax Center”) (NASDAQ: EWCZ) and General Atlantic. Investors who purchased European Wax Center and continue to hold to the present are encouraged to obtain additional information and assist the… read more
February 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICON plc (“ICON” or “the Company”) (NASDAQ: ICLR). Investors who purchased ICON securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ICON has violated federal… read more
February 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating whether the board members and senior executives of OneStream, Inc. (“OneStream” or the “Company”) (NASDAQ: OS) breached their fiduciary duties in connection with the Company’s proposed take-private transaction led by Hg Capital, with minority participation from General Atlantic and Tidemark…. read more
February 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of KDDI Corporation (“KDDI” or “the Company”) (OTCMKTS: KDDIY). Investors who purchased KDDI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether KDDI has violated federal… read more
February 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS). Investors who purchased Hims & Hers securities are encouraged to obtain additional information and assist the investigation. The… read more
February 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. (“Organon” or “the Company”) (NYSE: OGN). Investors who purchased Organon securities prior to November 3, 2022, and continue to hold to the present, are encouraged to obtain additional… read more
February 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Blue Owl Capital Inc. (“Blue Owl” or “the Company”) (NYSE: OWL). Investors who purchased Blue Owl securities prior to February 6, 2025, and continue to hold to the present, are encouraged… read more
February 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GSI Technology Inc. (“GSI Technology” or “the Company”) (NASDAQ: GSIT). Investors who purchased GSI Technology securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GSI… read more
February 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hub Group, Inc. (“Hub Group” or “the Company”) (NASDAQ: HUBG). Investors who purchased Hub Group securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Hub… read more
February 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integer Holdings Corporation (“Integer” or “the Company”) (NYSE: ITGR). Investors who purchased Integer securities prior to July 25, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
February 5, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XPeng Inc. (“XPeng” or “the Company”) (NYSE: XPEV). Investors who purchased XPeng securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether XPeng has violated federal… read more
February 5, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Yext, Inc. (“Yext” or “the Company”) (NYSE: YEXT). Investors who purchased Yext securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Yext has violated federal… read more
February 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pharming Group N.V. (“Pharming” or “the Company”) (NASDAQ: PHAR). Investors who purchased Pharming securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pharming has violated… read more
February 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Galaxy Digital Inc. (“Galaxy” or “the Company”) (NASDAQ: GLXY). Investors who purchased Galaxy securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Galaxy has violated… read more
February 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Graphic Packaging Holding Company (“Graphic Packaging” or “the Company”) (NYSE: GPK). Investors who purchased Graphic Packaging securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 3, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST). Investors who purchased Aquestive securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Aquestive has violated… read more
February 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PennyMac Financial Services, Inc. (“PennyMac” or “the Company”) (NYSE: PFSI). Investors who purchased PennyMac securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PennyMac has… read more
January 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vizsla Silver Corp. (“Vizsla” or “the Company”) (NYSE: VZLA). Investors who purchased Vizsla securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Vizsla has violated… read more
January 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Microsoft Corporation (“Microsoft” or “the Company”) (NASDAQ: MSFT). Investors who purchased Microsoft securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Microsoft has violated federal… read more
January 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Carvana Co. (“Carvana” or “the Company”) (NYSE: CVNA). Investors who purchased Carvana securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Carvana has violated federal… read more
January 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Danone S.A. (“Danone” or “the Company”) (OTCMKTS: DANOY). Investors who purchased Danone securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Danone has violated federal… read more
January 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brown & Brown, Inc. (“Brown & Brown” or “the Company”) (NYSE: BRO). Investors who purchased Brown & Brown securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
January 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capital One Financial Corporation (“Capital One” or “the Company”) (NYSE: COF). Investors who purchased Capital One securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
January 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of First Citizens BancShares, Inc. (“First Citizens” or “the Company”) (NASDAQ: FCNCA). Investors who purchased First Citizens securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
January 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of T1 Energy Inc. (“T1” or “the Company”) (NYSE: TE). Investors who purchased T1 securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether T1 has violated… read more
January 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Disc Medicine, Inc. (“Disc Medicine” or “the Company”) (NASDAQ: IRON). Investors who purchased Disc Medicine securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Disc… read more
January 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telesat Corporation (“Telesat” or “the Company”) (NASDAQ: TSAT). Investors who purchased Telesat securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Telesat has violated federal… read more
January 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Newegg Commerce, Inc. (“Newegg” or “the Company”) (NASDAQ: NEGG). Investors who purchased Newegg securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Newegg has violated… read more